Ind-Swift Laboratories Ltd. manufactures bulk drugs and intermediates. The Company’s product portfolio includes anti-infective, anti-allergy, analgesic, and cardiovascular medicines.
In India the business of Ind-Swift Laboratories Ltd. focuses on a process for the preparation of imatinib and its mesylate salt, an improved process for the preparation of imatinib and its mesylate salt, a process for preparing L-phenyl-3-dimethylaminopropane derivative, Process for the preparation of pure risedronic acid or salts, and Process for the preparation of ivabradine hydrochloride and polymorph thereof.
Ind-Swift Laboratories Ltd. filed a patent application numbered 3349/DEL/2013 that is titled PROCESS FOR THE PREPARATION OF 3-(2-BROMO-4,5-DIMETHOXYBENZENE) PROPIONITRILE. The patent has been filed in the field of Chemicals. This Patent Application has been granted as Patent Number 352680. This invention relates to an efficient and industrially advantageous process for preparation of 3-(2-Bromo-4,5-dimethoxybenzene) propionitrile of formula I, with high purity and high yield, wherein the compound of formula I is an important precursor of 1-cyano-4,5- dimethoxybenzocyclobutane, a key intermediate in the preparation of ivabradine or its pharmaceutically acceptable salts thereof.
During the patent examination, the Patent Examiner raised objections under Section 3(d) of the Patents Act, 1970 stating that the process as defined in the claims is not inventive. In view of the processes as mentioned in the prior art, the process of the invention would be considered as “the same process ” as per the clause/Act.
As a response, the Applicant submitted that by extensive experimentation, the inventors of the invention have reached specific reactions of a single pot without isolating intermediates and the associated costs involved therein and results in higher yields and high purity. Thus, the process as claimed in the invention is advantageous, cost-effective, and superior and may not fall u/s 3(d) of the Patents (Amendment) Act, 2005.
Advocate Rahul Dev is a Patent Attorney & International Business Lawyer practicing Technology, Intellectual Property & Corporate Laws. He is reachable at rd (at) patentbusinesslawyer (dot) com & @rdpatentlawyer on Twitter.
Quoted in and contributed to 50+ national & international publications (Bloomberg, FirstPost, SwissInfo, Outlook Money, Yahoo News, Times of India, Economic Times, Business Standard, Quartz, Global Legal Post, International Bar Association, LawAsia, BioSpectrum Asia, Digital News Asia, e27, Leaders Speak, Entrepreneur India, VCCircle, AutoTech).
Regularly invited to speak at international & national platforms (conferences, TV channels, seminars, corporate trainings, government workshops) on technology, patents, business strategy, legal developments, leadership & management.
